Buscar | Bundas24

Khushbu Coherent agregó una foto Health
2025-05-09 07:49:28 -

ATTR Amyloidosis Treatment Market is driven by Innovation
The ATTR Amyloidosis Treatment Market encompasses therapies focused on transthyretin stabilization and gene-silencing approaches to manage cardiomyopathy and polyneuropathy arising from amyloid fibril deposition. Market products include TTR stabilizers such as tafamidis and diflunisal, RNA interference (RNAi) drugs like patisiran, and antisense oligonucleotides exemplified by inotersen. These...

0 Commentarios 0 Acciones 233 Views 0 Vista previa

Please log in to like, share and comment!
Kislay Kumar agregó una foto Health
2025-05-29 09:06:42 -

Chronic Idiopathic Urticaria (CIU) Treatment Market Fueled by Biologics Growth
The global Chronic Idiopathic Urticaria (CIU) Treatment Market encompasses a broad spectrum of therapeutic interventions designed to mitigate the persistent hives and severe itching characteristic of CIU. First‐line treatments primarily involve second‐generation H1‐antihistamines, which offer rapid symptom relief and a favorable safety profile compared to first‐generation counterparts,...

0 Commentarios 0 Acciones 47 Views 0 Vista previa

Please log in to like, share and comment!
Kajalpatil Patil agregó una foto Health
2025-05-22 11:55:47 -

Medullary Thyroid Cancer Drugs Market Driven by Market Growth
The Medullary thyroid cancer drugs market comprises targeted therapies, tyrosine kinase inhibitors, and novel biologics specifically designed to manage calcitonin-producing malignancies. These products offer advantages such as improved specificity, reduced off-target toxicity, and better patient compliance compared with conventional chemotherapies. Targeted agents inhibit signaling pathways...

0 Commentarios 0 Acciones 111 Views 0 Vista previa

Please log in to like, share and comment!
Khushbu Coherent agregó una foto Health
2025-05-02 10:43:14 -

Refractory Angina Treatment Market is driven by Innovative TherapeuticsNew Section
Refractory angina, characterized by chronic chest pain unresponsive to standard medical and revascularization therapies, affects a significant subset of ischemic heart disease patients. The market offers a spectrum of advanced interventions—including novel pharmacological agents (such as ivabradine and ranolazine), gene therapy vectors, cell-based regenerative treatments, enhanced...

0 Commentarios 0 Acciones 309 Views 0 Vista previa

Please log in to like, share and comment!
Khushbu Coherent agregó una foto Health
2025-05-05 10:00:38 -

Transient Ischemic Attack Market is driven by advanced diagnostics
The Transient Ischemic Attack (TIA) Market comprises a diverse range of diagnostic, therapeutic, and monitoring products designed to manage and prevent transient ischemic attacks. These offerings include non-invasive imaging modalities such as CT scans and MRI, point-of-care biomarker assays, antiplatelet and anticoagulant medications, and advanced wearable devices for continuous patient...

0 Commentarios 0 Acciones 352 Views 0 Vista previa

Please log in to like, share and comment!